| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Wedbush analyst Martin Fan maintains Sana Biotechnology (NASDAQ:SANA) with a Outperform and raises the price target from $5...
HC Wainwright & Co. analyst Emily Bodnar maintains Sana Biotechnology (NASDAQ:SANA) with a Buy and lowers the price targ...
Sana Biotechnology (NASDAQ:SANA) reported quarterly losses of $(0.15) per share which beat the analyst consensus estimate of $(...
Citizens analyst Reni J. Benjamin maintains Sana Biotechnology (NASDAQ:SANA) with a Market Outperform and raises the price t...
Sana Biotech stock soars after outspoken stock promoter Eric Jackson names it as his latest potential "100-bagger."
Wedbush analyst Martin Fan initiates coverage on Sana Biotechnology (NASDAQ:SANA) with a Outperform rating and announces Pr...